Balyasny Asset Management’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-21,509
| Closed | -$55K | – | 2480 |
|
|
2022
Q3 | $55K | Buy |
+21,509
| New | +$55K | ﹤0.01% | 1983 |
|
|
2016
Q1 | – | Sell |
-35,160
| Closed | -$122K | – | 1156 |
|
|
2015
Q4 | $122K | Buy |
35,160
+20,110
| +134% | +$69.8K | ﹤0.01% | 1016 |
|
|
2015
Q3 | $57K | Sell |
15,050
-385
| -2% | -$1.46K | ﹤0.01% | 919 |
|
|
2015
Q2 | $88K | Buy |
15,435
+1,455
| +10% | +$8.3K | ﹤0.01% | 846 |
|
|
2015
Q1 | $81K | Buy |
+13,980
| New | +$81K | ﹤0.01% | 676 |
|